This fusion involves fibroblast growth factor receptor 3 (FGFR3) and transforming acidic coiled-coil containing protein 3 (TACC3), leading to the constitutive activation of oncogenic signaling pathways that promote tumor growth and progression [3,4]. Here, FGFR3 is linked to neoplasm.